Stevanato Group Spa (STVN)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt STVN? Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Stevanato Group Spa Stock (STVN) Company Profile

Stevanato Group Spa

Healthcare (1104)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

STVN's Discussions on Twitter

Compare STVN vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
STVN Stevanato Group Spa	17.54	4.79B	1.40B	164.00M	-11.09M	0.6009
ISRG Intuitive Surgical Inc	406.78	144.07B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	143.98	39.67B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	64.68	31.54B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	35.94	30.39B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	188.63	27.36B	5.54B	1.52B	1.74B	10.37

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-02	Fortgesetzt	Morgan Stanley	Equal-Weight
2024-12-13	Eingeleitet	Wolfe Research	Outperform
2024-12-03	Fortgesetzt	Morgan Stanley	Equal-Weight
2024-04-22	Eingeleitet	Exane BNP Paribas	Outperform
2023-11-01	Herabstufung	Jefferies	Buy → Hold
2023-09-26	Eingeleitet	Stephens	Overweight
2023-09-19	Eingeleitet	CJS Securities	Market Outperform
2023-08-24	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-08-10	Eingeleitet	BofA Securities	Buy
2021-08-10	Eingeleitet	Citigroup	Buy
2021-08-10	Eingeleitet	Jefferies	Buy
2021-08-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2021-08-10	Eingeleitet	Morgan Stanley	Overweight
2021-08-10	Eingeleitet	Wells Fargo	Overweight

Alle ansehen

Stevanato Group Spa Aktie (STVN) Neueste Nachrichten

Finanzdaten der Stevanato Group Spa-Aktie (STVN)

Stevanato Group Spa (STVN)

Stevanato Group Spa Stock (STVN) Company Profile

Compare STVN vs ISRG, BDX, ALC, MDLN, RMD

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Stevanato Group Spa Aktie (STVN) Neueste Nachrichten

Stevanato Group SpA (STVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Stevanato Group SpA (STVN) Institutional Confidence - TradingKey

Stevanato Group SpA (STVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

(STVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Stevanato Group SpA (STVN) Valuation: PE, PB & Fair Value Analysis - TradingKey

Stevanato Group SpA (STVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Stevanato Group SpA (STVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Stevanato Group SpA (STVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Stevanato Group SpA (STVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Stevanato Group SpA (STVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

TD Cowen initiates Stevanato stock with buy rating on margin outlook - Investing.com

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 42.79% Potential Upside in the Medical Instruments Sector - DirectorsTalk Interviews

Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness - Yahoo Finance

Sustainable Pharmaceutical Packaging Market to Reach USD 270.4 Billion by 2031, Wissen Research - Moomoo

Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now? - Insider Monkey

Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside - Seeking Alpha

Stevanato Group launches pen injector for diabetes drugs By Investing.com - Investing.com Nigeria

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now - The Motley Fool

Stevanato Group launches Deora pen injector platform targeting GLP-1 and incretin therapies - Manufacturing Chemist

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneo - GuruFocus

Stevanato Group (STVN) Q1 2026 Earnings: EPS Beats Estimates Amid Quiet Revenue DisclosureShort-Term Outlook - newsline.com

Stevanato Group Launches Deora Pen Injector for Diabetes and Weight Management Therapies - World Business Outlook

Stevanato Group launches pen injector platform targeting GLP-1, obesity drug market - Medical Economics

Stevanato Group Introduces New Proprietary Pen Injector Platform - Contract Pharma

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management - Stevanato Group S.p.A. (STVN)

Stevanato Group launches pen injector for diabetes drugs - Investing.com UK

Stevanato Group S.p.A. (STVN): Analyst Consensus Highlights 32.12% Potential Upside - DirectorsTalk Interviews

Stevanato Group S.p.A (STVN) Q4 2023 Earnings Call Transcript - MLQ.ai

(STVN) Risk Channels and Responsive Allocation - Stock Traders Daily

Stevanato Group (STVN) Holds Steady Near Support as Market Weighs FundamentalsBollinger Band - newsline.com

[6-K] Stevanato Group S.p.A. Current Report (Foreign Issuer) | STVN SEC FilingForm 6-K - Stock Titan

Stevanato faces earnings test on high-value product mix shift By Investing.com - Investing.com UK

Stevanato faces earnings test on high-value product mix shift - Investing.com

Stevanato Group’s Quiet Revolution: Governance for a Modern Era - BriefGlance

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting - Stevanato Group S.p.A. (STVN)

Implied Volatility Surging for Stevanato Stock Options - Yahoo Finance

STVN Assumes Outperform by Wolfe Research -- Price Target Announ - GuruFocus

Wolfe Research initiates Stevanato stock with Outperform rating By Investing.com - Investing.com India

Wolfe Research initiates Stevanato stock with Outperform rating - Investing.com

Stevanato Group S.p.A. (STVN) Stock Analysis: An Under-the-Radar Healthcare Gem with 33% Upside Potential - DirectorsTalk Interviews

Stevanato’s GLP-1 Tailwinds Meet A Guidance Reality Check - Finimize

Stevanato Group (STVN) Holds Steady Near $18.66 as Consolidation BuildsHigh Volume Node - newsline.com

Stevanato Group (STVN) Q1 2026 Earnings: EPS Beat Drives Shares Higher Despite Revenue UncertaintyEarnings Decline Risk - newsline.com

Stevanato Group SpA (N: STVN) Share Price, STVN Stock News, STVN Share Price & Updates - Kalkine

Stevanato Group (STVN) Edges Lower Amid Light Trading, Holds Near Key SupportVolume Spike Alerts - newsline.com

(STVN) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Finanzdaten der Stevanato Group Spa-Aktie (STVN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie STVN